Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005203947
Mon, 30.08.2021
BRAIN Biotech AG
Zwingenberg, Germany, August 30th, 2021
BRAIN Biotech AG 9M '20/'21 Results
Solid Progress on Incubator Pipeline
Capital Markets Day: Focus BEC, September 3rd
Full Year Guidance Confirmed
Today, BRAIN Biotech AG (BRAIN, ISIN DE0005203947 / WKN 520394) published its results for the period from April 1st, 2021 to June 30th, 2021. In the first ni [ … ]
Wed, 28.07.2021
BRAIN Biotech AG
Goettingen / Zwingenberg (Germany), July 28, 2021
Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases
The life science group Sartorius and BRAIN Biotech AG are jointly researching and adapting novel CRISPR-Cas genome editing nucleases for specific applications in the field of life sciences. Genome editing enables the t [ … ]
Wed, 21.07.2021
BRAIN Biotech AG
Zwingenberg (Germany), July 21st, 2021Novel Genome Editing Tool: Filing of International Patent Application
Positive data evaluation
Management sees strong IP position
Seeking international patent protection (PCT)
Positive data evaluation from recently conducted experiments has increased confidence of BRAIN Biotech AG's management in the valuab [ … ]
Thu, 15.07.2021
BRAIN Biotech AG
Zwingenberg (Germany), July 15th, 2021Additional CRISPR Genome Editing Nucleases Identified
Around 2,000 Class 2 CRISPR Nucleases identified
Selective additional IP protection filed
Partnering discussions started
BRAIN Biotech AG has identified around 2,000 so far untapped additional Class 2 CRISPR Nucleases using metagenomics sequencing which [ … ]
Tue, 08.06.2021
BRAIN Biotech AG
Zwingenberg, Germany, June 8, 2021BRAIN actively supports the UN Global Compact
BRAIN Biotech AG, Germany, now actively supports the UN Global Compact, a voluntary initiative based on company commitments to implement universal sustainability principles and to advance United Nations goals such as the Sustainable Development Goals (SDGs). With our c [ … ]
Fri, 28.05.2021
BRAIN Biotech AG
Zwingenberg, Germany, May 28th, 2021
BRAIN Biotech AG H1 '20/'21 Results
CRISPR Associated Nuclease with large business potential
New Pharma Compound PHA121 enters incubator
Biocatalysts Ltd. producing soon close to capacity limit
Today, BRAIN Biotech AG (BRAIN, ISIN DE0005203947 / WKN 520394) published its results for the period from October [ … ]
Wed, 12.05.2021
BRAIN Biotech AG
Zwingenberg, Germany, May 12, 2021BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.
BRAIN has acquired additional shares in Biocatalysts Ltd.
Biocatalysts strong business trend
Planned additional capacity expansion now targeted earlier
BRAIN Biotech AG has expanded its shareholdings in the successful enzyme producer [ … ]
Thu, 06.05.2021
BRAIN Biotech AG
Zwingenberg, Germany, May 6th, 2021Genome Editing Tool Developed by BRAIN
- Novel CRISPR Cas system
- Holding significant economic potential
- Different commercialization models currently being explored
BRAIN Biotech AG has successfully completed the first development phase for a novel genome editing CRISPR Cas system applying its advanced met [ … ]
Thu, 06.05.2021
BRAIN Biotech AG
BRAIN Biotech AG: First Development Phase for a novel Genome Editing Tool Completed (CRISPR Cas)
Zwingenberg, Germany
May 6th, 2021
BRAIN Biotech AG ("BRAIN") has successfully completed the first development phase for a novel genome editing tool based on a Non-Cas9 nuclease. It has been validated as a genome editing tool and the tool has been demo [ … ]
Thu, 14.01.2021
B.R.A.I.N. Biotechnology Research And Information Network AG
Zwingenberg, Germany, 14 January, 2021BRAIN AG publishes its Annual Report for the Financial Year 2019/20
Today, B.R.A.I.N. Biotechnology Research and Information Network AG ("BRAIN AG") published its annual report 2019/20 including the detailed consolidated financial statements for the financial year 2019/20.
The BRAIN Group reported 3.4% organi [ … ]